Chemische Charakterisierung und Spurenanalytik
Filtern
Dokumenttyp
- Zeitschriftenartikel (26) (entfernen)
Sprache
- Englisch (26)
Schlagworte
- Magnetic resonance imaging (4)
- Mass spectrometry (4)
- HPLC (3)
- Metrology (3)
- Quality control (3)
- Traceability (3)
- Affinity chromatography (2)
- Amino acid analysis (2)
- Aromatic amino acid analysis (2)
- Chromatography (2)
- Copper (2)
- Diagnosis (2)
- Diagnostics (2)
- ELISA (2)
- Fluorescence (2)
- Imaging (2)
- MALDI (2)
- Mobile phase (2)
- Nickel (2)
- Nitrotyrosine (2)
- Peptide analysis (2)
- Permethrin (2)
- Phenylalanine (2)
- Quantitative protein analysis (2)
- Reference material (2)
- Reproducibility (2)
- SBA-15 (2)
- Screening (2)
- Tyrosine (2)
- 150th anniversary of BAM (1)
- 2,5-dihydroxyacetophenone (1)
- 280 nm (1)
- 6xHis (1)
- AAA (1)
- AAAA (1)
- ABID (1)
- ATCUN (1)
- Acute myocardial infarction (1)
- Additive Manufacturing (1)
- Adsorption (1)
- Affinity Chromatography (1)
- Affinity Extraction (1)
- Affinity Separation (1)
- Affinity extraction (1)
- Air filter samples (1)
- Air particulate matter (1)
- Airport (1)
- Allergy (1)
- Aluminum oxide (1)
- Amplification (1)
- Anthropocene (1)
- Antibody Purification (1)
- Antibody antigen complex (1)
- Antibody identification (1)
- Antibody quality (1)
- Antibody quantification (1)
- Antibody-gated indicator delivery (1)
- Array (1)
- Atmospheric aerosol (1)
- Automated Purification (1)
- Aviation (1)
- BCA test (1)
- Back-side integration (1)
- Bacterial lysates (1)
- Basic solvent (1)
- Benzene-1,3,5-tricarboxylic acid (1)
- Binder (1)
- Binding strength (1)
- Bio-interaction (1)
- Biochip (1)
- Biomarker (1)
- Biosensing (1)
- Biosensor (1)
- Biosensors (1)
- Bioseparation (1)
- Block copolymer (1)
- Bombs (1)
- Borosilicate Glass (1)
- Bovine serum albumin (BSA) (1)
- Bradford (1)
- Byproducts (1)
- COVID-19 (1)
- Calibration (1)
- Cancer (1)
- Cardiac troponin (1)
- Cardiovascular (1)
- Carrier (1)
- Chemical protein modification (1)
- Chemiluminescence (1)
- Chicken antibodies (1)
- Chronic kidney disease (1)
- Citizen Science (1)
- Cleavage (1)
- Clone M2 (1)
- Column holder (1)
- Combustion (1)
- Competitive immunoassay (1)
- Compound-independent calibration (1)
- Concentration step (1)
- Construction (1)
- Continuous Sensor (1)
- Corona virus (1)
- Cytoplasm (1)
- DHAP (1)
- Damage-associated molecular patterns (DAMPs) (1)
- Degradation (1)
- Derivatization (1)
- Diagnostic Antibodies (1)
- Diesel exhaust (1)
- Dissociation constant (1)
- Dityrosine (1)
- Down Stream Processing (1)
- Downstream processing (1)
- Drug transporters (1)
- EDTAD (1)
- ESMA (1)
- Elastin-specific contrast agent ESMA (1)
- Elastin-specific molecular agent (1)
- Element Specific Bioimaging Using Laser Ablation (1)
- Emergency (1)
- Environmental pollutants (1)
- Equilibrium constant (1)
- Escherichia coli (1)
- Ethylenediaminetetraacetic acid (1)
- Etofenprox (1)
- Exhaust (1)
- Extracellular matrix (1)
- FLAG peptide (1)
- FPLC (1)
- Flow injection immunoassay (1)
- Formulation additives (1)
- Gadofosveset (1)
- Gadolinium (1)
- Gadolinium-based contrast agent (1)
- Gadovist (1)
- Gated hybrid material (1)
- Github (1)
- Glass Support (1)
- HTS (1)
- Hay fever (1)
- Heart attack (1)
- Hepatocellular carcinoma (1)
- HexaHis-Tag (1)
- High pH (1)
- High-Speed (1)
- High-Speed Separations (1)
- His6 (1)
- His8 (1)
- Histidine (1)
- Human Plasma (1)
- Hybridoma (1)
- Hydrochloric acid (1)
- Hydrolysis (1)
- IC50 (1)
- ICP-MS (1)
- IMAC purification (1)
- Identity (1)
- IgG determination (1)
- IgY (1)
- Iinductively coupled plasma mass spectrometry (1)
- Immunoaffinity extraction (1)
- Immunoassays (1)
- Immunocapture (1)
- Immunometric assay (1)
- Immunometric biosensor (1)
- Immunosensor (1)
- Impurites (1)
- Inductively Coupled Mass Spectroscopy (1)
- Inductively coupled plasma mass spectroscopy (1)
- Insecticide (1)
- Internal standard (1)
- Iron disorders (1)
- Iron oxide (1)
- Isotope dilution (1)
- Kjeldahl (1)
- LC-UV absorbance (1)
- Lab-on-a-Chip (1)
- Lab-on-a-chip (1)
- Ladder sequencing (1)
- Laser ablation-inductively coupled plasma-mass spectrometry (1)
- Lateral flow assay (1)
- Lateral flow test (1)
- Library (1)
- Light chain (1)
- Liquid chromatography (1)
- Luminol (1)
- MR Angiography (1)
- MR imaging (1)
- MRI (1)
- Mesoporous particles (1)
- Metalloprotein (1)
- Microfluidic system (1)
- Molecular imaging (1)
- Molecular marker (1)
- Molecular-MRI (1)
- Monoclonal Antibodies (1)
- Monoclonal Antibody (1)
- Monoclonal antibodies (1)
- Monoclonal antibody (1)
- Monolith (1)
- Monolithic column (1)
- NIST (1)
- NIST-mAb 8671 (1)
- Nanoparticle (1)
- Nickel chelate (1)
- Nitration (1)
- Nucleocapsid (1)
- Online biosensor (1)
- Open Science (1)
- Open science (1)
- Optical detection (1)
- Orbitrap (1)
- PIC technology (1)
- Pattern recognition receptor (1)
- Peptide (1)
- Peptide library (1)
- Peptide library screening (1)
- Peptide losses (1)
- Peptide mass fingerprinting (1)
- Peptides (1)
- Peroxidase (1)
- Pesticide (1)
- Pharmaceutical (1)
- Phenothrin (1)
- Phenylketonuria (1)
- Photonic biosensor (1)
- Point of inflection (1)
- Polishing (1)
- Pollen extract (1)
- Polyclonal Antibodies (1)
- Prostate cancer (1)
- Protein (1)
- Protein A (1)
- Protein Purification (1)
- Protein content (1)
- Protein hydrolysis (1)
- Protein nitration (1)
- Protein oligomerization (1)
- Protein quantification (1)
- Protein test (1)
- Purity (1)
- Pyrethroid (1)
- QC (1)
- Quality Control (1)
- RBD (1)
- Recombinant Antibody (1)
- Recombinant antibody (1)
- Recombinant protein (1)
- Recovery (1)
- Reference materials (1)
- Regeneration (1)
- Resonance wavelength shift (1)
- Ring resonator (1)
- Robustness (1)
- Round robin exercise (1)
- Round robin test (1)
- SBA-16 (1)
- SI traceability (1)
- SPR (1)
- Sapphire (1)
- Sequence coverage (1)
- Sequencing (1)
- Silanization (1)
- Sintered Material (1)
- Smartphone readout device (1)
- Software (1)
- Spike protein (1)
- Sulfur (1)
- Surface-plasmon resonance (1)
- Synthetic peptides (1)
- Target (1)
- Terephthalic acid (1)
- Terrorism (1)
- Test midpoint (1)
- Therapeutic Antibodies (1)
- Topical collection: Analytical Methods and Applications in the Materials and Life Sciences (1)
- Tryptic digest (1)
- Tryptophan (1)
- Type-I pyrethroids (1)
- Ultrasensitive (1)
- Validation (1)
- Visualization (1)
- Zenodo (1)
Organisationseinheit der BAM
- 1.5 Proteinanalytik (26) (entfernen)
Thousands of antibodies for diagnostic and other analytical purposes are on the market. However, it is often difficult to identify duplicates, reagent changes, and to assign the correct original publications to an antibody. This slows down scientific progress and might even be a cause of irreproducible research and a waste of resources. Recently, activities were started to suggest the sole use of recombinant antibodies in combination with the open communication of their sequence. In this case, such uncertainties should be eliminated. Unfortunately, this approach seems to be rather a long-term vision since the development and manufacturing of recombinant antibodies remain quite expensive in the foreseeable future. Nearly all commercial antibody suppliers also may be reluctant to publish the sequence of their antibodies, since they fear counterfeiting. De novo sequencing of antibodies is also not feasible today for a reagent user without access to the hybridoma clone. Nevertheless, it seems to be crucial for any scientist to have the opportunity to identify an antibody undoubtedly to guarantee the traceability of any research activity using antibodies from a third party as a tool. For this purpose, we developed a method for the identification of antibodies based on a MALDI-TOF MS fingerprint. To circumvent lengthy denaturation, reduction, alkylation, and enzymatic digestion steps, the fragmentation was performed with a simple formic acid hydrolysis step. Eighty-nine unknown monoclonal antibodies were used for this study to examine the feasibility of this approach. Although the molecular assignment of peaks was rarely possible, antibodies could be easily recognized in a blinded test, simply from their mass-spectral fingerprint. A general protocol is given, which could be used without any optimization to generate fingerprints for a database. We want to propose that, in most scientific projects relying critically on antibody reagents, such a fingerprint should be established to prove and document the identity of the used antibodies, as well as to assign a specific reagent to a datasheet of a commercial supplier, public database record, or antibody ID.
Screening of one-bead-one-compound (OBOC) libraries is a proven procedure for the identification of protein-binding ligands. The demand for binders with high affinity and specificity towards various targets has surged in the biomedical and pharmaceutical field in recent years. The traditional peptide screening involves tedious steps such as affinity selection, bead picking, sequencing, and characterization. Herein, we present a high-throughput “all-on-one chip” system to avoid slow and technically complex bead picking steps. On a traditional glass slide provided with an electrically conductive tape, beads of a combinatorial peptide library are aligned and immobilized by application of a precision sieve. Subsequently, the chip is incubated with a fluorophore-labeled target protein. In a fluorescence scan followed by matrix-assisted laser desorption/ionization (MALDI)-time of flight (TOF) mass spectrometry, high-affinity binders are directly and unambiguously sequenced with high accuracy without picking of the positive beads. The use of an optimized ladder sequencing approach improved the accuracy of the de-novo sequencing step to nearly 100%. The new technique was validated by employing a FLAG-based model system, identifying new peptide binders for the monoclonal M2 anti-FLAG antibody, and was finally utilized to search for IgG-binding peptides. In the present format, more than 30,000 beads can be screened on one slide.
Hepcidin-25 was identified as the main iron regulator in the human body, and it by binds to the sole iron-exporter ferroportin. Studies showed that the N-terminus of hepcidin is responsible for this interaction, the same N-terminus that encompasses a small copper(II)-binding site known as the ATCUN (amino-terminal Cu(II)- and Ni(II)-binding) motif. Interestingly, this copper-binding property is largely ignored in most papers dealing with hepcidin-25. In this context, detailed investigations of the complex formed between hepcidin-25 and copper could reveal insight into its biological role. The present work focuses on metal-bound hepcidin-25 that can be considered the biologically active form. The first part is devoted to the reversed-phase chromatographic separation of copper-bound and copper-free hepcidin-25 achieved by applying basic mobile phases containing 0.1% ammonia. Further, mass spectrometry (tandem mass spectrometry (MS/MS), high-resolution mass spectrometry HRMS)) and nuclear magnetic resonance (NMR) spectroscopy were employed to characterize the copper-peptide. Lastly, a three-dimensional (3D)model of hepcidin-25with bound copper(II) is presented. The identification of metal complexes and potential isoforms and isomers, from which the latter usually are left undetected by mass spectrometry, led to the conclusion that complementary analytical methods are needed to characterize a peptide calibrant or reference material comprehensively. Quantitative nuclear magnetic resonance (qNMR), inductively-coupled plasma mass spectrometry (ICP-MS), ion-mobility spectrometry (IMS) and chiral amino acid analysis (AAA) should be considered among others.
A 2-dimensional high-throughput screening method is presented to select peptide sequences from large peptide libraries for precision formulation additives, having a high capacity to specifically host a drug of interest and provide tailored drug release properties. The identified sequences are conjugated with poly(ethylene glycol) (PEG) to obtain peptide-PEG conjugates that proved to be valuable as solubilizers for small organic molecule drugs to overcome limitations of poor water-solubility and low bio-availability. The 2D-screening method selects peptide sequences on both (i) high loading capacities and (ii) preferred drug-release capabilities as demonstrated on an experimental Tau-protein aggregation inhibitor/Tau- deaggregator with potentials for an anti-Alzheimer disease drug (BB17). To enable 2D-screening, a one-bead one-compound (OBOC) peptide library was immobilized on a glass slide, allocating individual beads to permanent positions. While the first screening step involved incubation of the supported OBOC library with BB17 to identify beads with high drug binding capacities by fluorescence scanner readouts, the second step reveals release properties of the high capacity binders by incubation with blood plasma protein model solutions. Efficiently peptides with high BB17 capacities and either keeper or medium or fast releaser properties can be identified by direct sequence readouts from the glass slide supported resin beads via matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry. Four peptides are synthesized as peptide-PEG solubilizers representing strong, medium, weak releasers and non-binders. Loading capacities reached up to 1:3.4 (mol drug per mol carrier) and release kinetics (fast/medium/slow) are in agreement with the selection process as investigated by fluorescence anisotropy and fluorescence correlation spectroscopy. The ability of BB17/conjugate complexes to inhibit the aggregation of Tau4RDΔK (four repeat Tau ((M)Q244-E372 with deletion of K280), 129 residues) in N2a cells is studied by a Tau-pelleting assay showing the modulation of cellular Tau aggregation. Promising effects such as the reduction of 55% of total Tau load are observed for the strong releaser additive. Studies of in vitro Thioflavin S Tau-aggregation assays show half-maximal inhibitory activities (IC50 values) of BB17/conjugates in the low micro-molar range.
Mass spectrometry-based methods play a crucial role in the quantification of the main iron metabolism regulator hepcidin by singling out the bioactive 25-residue peptide from the other naturally occurring N-truncated isoforms (hepcidin-20, -22, -24), which seem to be inactive in iron homeostasis. However, several difficulties arise in the MS analysis of hepcidin due to the sticky character of the peptide and the lack of suitable standards. Here, we propose the use of amino- and fluoro-silanized autosampler vials to reduce hepcidin interaction to laboratory glassware surfaces after testing several types of vials for the preparation of stock solutions and serum samples for isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS). Furthermore, we have investigated two sample preparation strategies and two chromatographic separation conditions with the aim of developing an LC-MS/MS method for the sensitive and reliable quantification of hepcidin-25 in serum samples. A chromatographic separation based on usual acidic mobile phases was compared with a novel approach involving the separation of hepcidin-25 with solvents at high pH containing 0.1% of ammonia. Both methods were applied to clinical samples in an intra-laboratory comparison of two LC-MS/MS methods using the same hepcidin-25 calibrators with good correlation of the results. Finally, we recommend an LC-MS/MS-based quantification method with a dynamic range of 0.5–40 μg/L for the assessment of hepcidin-25 in human serum that uses TFA-based mobile phases and silanized glass vials.
Online immunocapture ICP‑MS for the determination of the metalloprotein ceruloplasmin in human serum
(2018)
The human copper-protein ceruloplasmin (Cp) is the major copper-containing protein in the human body. The accurate determination of Cp is mandatory for the reliable diagnosis of several diseases. However, the analysis of Cp has proven to be difficult. The aim of our work was a proof of concept for the determination of a metalloprotein-based on online immunocapture ICP-MS. The immuno-affinity step is responsible for the enrichment and isolation of the analyte from serum, whereas the compound-independent quantitation with ICP-MS delivers the sensitivity,
precision, and large dynamic range. Off-line ELISA (enzyme-linked immunosorbent assay) was used in parallel to confirm the elution profile of the analyte with a structure-selective method. The total protein elution was observed with the 32S mass trace. The ICP-MS signals were normalized on a 59Co signal. The human copper-protein Cp could be selectively determined. This was shown with pure Cp and with a sample of human serum. The good correlation with off-line ELISA shows that Cp could be captured and eluted selectively from the anti-Cp affinity column and subsequently determined by the copper signal of ICP-MS.